Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.
- DOI
- 10.2174/0115748871503065260901071735
- Published
- 2026 Sep 18
- Container
- Reviews on recent clinical trials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0115748871503065260901071735,
title = {Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.},
author = {Naudiyal M and Pannu A and Gangotri S and Kumar U and Rao SK},
year = {2026},
journal = {Reviews on recent clinical trials},
doi = {10.2174/0115748871503065260901071735},
url = {https://doi.org/10.2174/0115748871503065260901071735}
}RIS
TY - JOUR TI - Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards. AU - Naudiyal M AU - Pannu A AU - Gangotri S AU - Kumar U AU - Rao SK PY - 2026 JO - Reviews on recent clinical trials DO - 10.2174/0115748871503065260901071735 UR - https://doi.org/10.2174/0115748871503065260901071735 ER -
APA
M, N., A, P., S, G., U, K., & SK, R. (2026). Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.. Reviews on recent clinical trials. https://doi.org/10.2174/0115748871503065260901071735
Source records
- pubmed · retrieved 2026-09-26T01:05:07.126Z